This Solicitation opportunity from Department Of Defense was posted on July 27, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
ISONIAZID TABLETS
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
ISONIAZID TABLETS, 300 MG, in bottles of 100 tablets per unit of issue, are being procured under solicitation SPE2DP-26-T-4307 for the U.S. Department of Defense. The product is regulated by the FDA and must comply with all applicable USP standards and DLA technical and quality requirements referenced in the DLA Master List. It has a non-extendable shelf life of 36 months and must be labeled and packaged in strict accordance with MIL-STD-129 and the Medical Marking Standard No. 1, with packaging following RP001 guidelines unless the material is hazardous, in which case FED-STD-313 and TQ requirement IP025 apply. Mercury or mercury-containing compounds are prohibited from intentional addition or direct contact with the product except for specific allowable uses such as batteries or instruments as defined by NAVSEA, with portable devices requiring shockproof construction and secondary containment. The contract specifies delivery of two bottles FOB destination within 20 days, with no variance allowed in quantity. The items must be shipped via fastest traceable means, not parcel post, to the FPO address, with shipment details tied to RDD 777 and DLA Vendor Shipping Method. The manufacturer identifiers include MARLEX PHARMACEUTICALS INC with NDC 10135-0805-01 and GENUS LIFESCIENCES INC with NDC 64950-0217-10. The contract is active with a response deadline of August 3, 2026, and a required delivery date of July 29, 2026, under NAICS code 325412 for pharmaceutical preparation manufacturing.
General Info
Agency
NAICS
Place of Performance
BOX 1, FPO, AP, 96692, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
ISONIAZID TABLETS<(>,<)> USP, 300 MG,100'S UNIT OF ISSUE "BOTTLE". Store at medical controlled room temperature.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
MERCURY OR MERCURY CONTAINING COMPOUNDS SHALL
NOT BE INTENTIONALLY ADDED TO<(>,<)> OR COME IN DIRECT
CONTACT WITH<(>,<)> ANY HARDWARE OR SUPPLIES FURNISHED
UNDER THIS CONTRACT. EXCEPTION: FUNCTIONAL MERCURY
USED IN BATTERIES, FLUORESCENT LIGHTS, REQUIRED
INSTRUMENTS; SENSORS OR CONTROLS; WEAPON SYSTEMS;
AND CHEMICAL ANALYSIS REAGENTS SPECIFIED BY NAVSEA.
PORTABLE FLUORESCENT LAMPS AND PORTABLE INSTRUMENTS
CONTAINING MERCURY SHALL BE SHOCK PROOF AND CONTAIN
A SECOND BOUNDARY OF CONTAINMENT OF THE MERCURY OR
MERCURY COMPOUND. (IAW NAVSEA 5100-003D).
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/
MARLEX PHARMACEUTICALS INC 1TAP7 P/N NDC10135080501 GENUS LIFESCIENCES INC 7BH52 P/N NDC64950-0217-10
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
SPE2DP-26-T-4307
SECTION B
PR: 7017624049 PRLI: 0001 CONT’D
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017624049 0001 BT 2.000
NSN/MATERIAL:6505001326904
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
R21660
USS BARRY DDG 52
UNIT 100278
BOX 1
FPO AP 96692
US
VESSEL SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
NOTE C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
R21660
USS BARRY DDG 52
DLA VENDORS: USE VSM FOR
US
RDD 777 SHIPMENT. SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
M/F: (TCN) R216606203HM83
RDD: 777
PROJ: EP5 TP 3
SUPP ADD: YNHM01 SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 11
SPE2DP-26-T-4307
SECTION B
PR: 7017624049 PRLI: 0001 CONT’D
DIC: A4A DIST: 9B ADV: 2A FC: N7
Need Ship Date:00/00/0000 Original Required Delivery Date:07/29/2026
SPE2DP-26-T-4307 NSN/Part Number: 6505-00-132-6904 Quantity: 2 BT Purchase Request: 7017624049QTY: 2 Delivery: 20 days ADO
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS